Form D · Biotechnology
Nexalin Technology, Inc.
Irvine, CA · CIK 0001527352
Offering snapshot reported Aug 9, 2011 · SEC filing
- Reported sold
- $502K Offering amount: $3.53M
- Investors reported
- 113 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Mar 16, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 9, 2011 | Initial | $501,705 | No comparison | 113 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-164087
Source: Form D, filed Aug 9, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Randall M. Letcavage | Director, Executive |
| Louis J. Lopez | Executive |
| Teresa Nguyen | Executive |
| Nancy Nguyen | Executive |
| Brad Shupe | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
18101 Von Karman Avenue, 3rd Floor
Irvine, CA, 92612
Irvine, CA, 92612